Molecular Genetics of Medulloblastoma in Children: Diagnostic, Therapeutic and Prognostic Implications
Authors:
Open Access
- 25 January 2019
- journal article
- review article
- Published by Taylor & Francis in Future Neurology
- Vol. 14 (1)
Abstract
No abstract availableKeywords
This publication has 86 references indexed in Scilit:
- TERT promoter mutations are highly recurrent in SHH subgroup medulloblastomaActa Neuropathologica, 2013
- Subgroup-specific structural variation across 1,000 medulloblastoma genomesNature, 2012
- Medulloblastoma exome sequencing uncovers subtype-specific somatic mutationsNature, 2012
- Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomasActa Neuropathologica, 2012
- Molecular subgroups of medulloblastoma: the current consensusActa Neuropathologica, 2011
- Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samplesActa Neuropathologica, 2011
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-MycCell, 2011
- Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroupsActa Neuropathologica, 2011
- Subtypes of medulloblastoma have distinct developmental originsNature, 2010
- Epigenetics in cancerCarcinogenesis, 2009